Investor Insight
  • Home
  • About
  • Nasdaq 100 Index
  • Products
Sign in Subscribe

VRTX

A collection of 1 post
VRTX

Vertex Pharmaceuticals Incorpor (2025-12-31)

AI EQUITY RESEARCH July 02, 2026 Vertex Pharmaceuticals Incorpor VRTX Healthcare Rating Underperform Price $498.01 Target $448.27 Pitroski Score 6 Market Cap $116.97B P/E (Fwd) 29.6x P/B Ratio 6.27x ROE 22.5% Div. Yield N/A 52W Range $366.54 - $499.65
03 Jul 2026 8 min read
Page 1 of 1
Investor Insight © 2026
  • Sign up
Powered by Ghost